GLP-1 Medication Persistence, a Key Component of Weight Loss
Medication persistence, or remaining on a medication as prescribed, is crucial for meaningful obesity management outcomes.
Read White paper
Explore more profound levels of insights and perspectives with virtual health and chronic care white papers from the Omada Insights Lab. Explore in-depth reports and guides on our approach and proven outcomes.
Medication persistence, or remaining on a medication as prescribed, is crucial for meaningful obesity management outcomes.
Read White paper
Error - something went wrong!
Product Innovation Launch
Thank you for registering!
What do doctors think of GLP-1s? New survey reveals prescription trends, patient safety concerns, and how telehealth prescribers affect care amidst rising demand for weight loss medications.
Read White paper
Is keeping weight off after GLP-1s a concern for your members? Omada’s 16-week analysis reveals how tailored tools and support can help lead to successful weight maintenance.
Read White paper
Become an Omada Insider, subscribe to our monthly newsletter.
Sign me up
How Omada Works
Discover early outcomes and insights on health behavior and weight loss with Omada's Enhanced GLP-1 Care Track, specifically designed for individuals on GLP-1s seeking supportive programs.
Read White paper
The collaboration between Stanford Health Care and Omada demonstrates the value of engaging with providers and health systems to realize the value of virtual care.
Read White paper
Omada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.
Read White paper
New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1
Read White paper
With its checkered past and at times questioned clinical merits, BMI’s ubiquity in modern healthcare should be carefully considered.
Read White paper
Medicare Advantage members thrive with virtual care. Contrary to popular belief, older adults engage with Omada Health chronic care management programs more than younger populations.
Read White paper
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read White paper
Analysis shows GLP-1s are twice as effective with lifestyle support programs. Download this free report by Omada Health and Express Scripts to learn more.
Read White paper
What's the best diet for weight loss? Omada’s clinical team surveyed 1,658 members to discover what type of dietary approaches have been most effective and sustainable.
Read White paper
Read White paper
In this paper, we’ll lay out our view on what customers should look for and what questions they should ask when evaluating digital health offerings.
Read White paper
As employers assess the ROI of diabetes prevention programs, new analysis shows that focusing on weight loss may be obscuring the real sources of value.
Read White paper
Through a uniquely personal virtual-first care model, Omada’s dedicated care teams across all of our programs—Prevention, Hypertension, Diabetes, and Musculoskeletal.
Read White paper
In the growing market for virtual care, Omada Health has continued to deliver proven health outcomes and ROI for its customers. Now with the Omada Insights Lab, the company unveils the interdisciplina
Read White paper
A new analysis from Omada Insights Lab shows that changing patients’ mindsets is a critical factor in improving behavior and health outcomes in diabetes prevention
Read White paper
Read White paper
Read White paper
Loading More...